CD274 and cancer: PDL1 intensity was also linked to the neoantigen signature in Rizvi samples (Fig. 4D), reflecting inflammation status or infiltrated-inflamed TME of immunologically ‘hot’ tumors [17], and potentially concomitant inhibition on antitumor T cell response through constitutively expressing PDL1 by cancer cells [18, 19].